Tomassini Luca, Ricchezze Giulia, Fedeli Piergiorgio, Lancia Massimo, Gambelunghe Cristiana, De Micco Francesco, Cingolani Mariano, Scendoni Roberto
International School of Advanced Studies, University of Camerino, 62032 Camerino, Italy.
Department of Law, Institute of Legal Medicine, University of Macerata, 62100 Macerata, Italy.
Diagnostics (Basel). 2024 May 30;14(11):1151. doi: 10.3390/diagnostics14111151.
Sudden unexpected deaths often remain unresolved despite forensic examination, posing challenges for pathologists. Molecular autopsy, through genetic testing, can reveal hidden causes undetectable by standard methods. This review assesses the role of molecular autopsy in clarifying SUD cases, examining its methodology, utility, and effectiveness in autopsy practice. This systematic review followed PRISMA guidelines and was registered with PROSPERO (registration number: CRD42024499832). Searches on PubMed, Scopus, and Web of Science identified English studies (2018-2023) on molecular autopsy in sudden death cases. Data from selected studies were recorded and filtered based on inclusion/exclusion criteria. Descriptive statistics analyzed the study scope, tissue usage, publication countries, and journals. A total of 1759 publications from the past 5 years were found, with 30 duplicates excluded. After detailed consideration, 1645 publications were also excluded, leaving 84 full-text articles for selection. Out of these, 37 full-text articles were chosen for analysis. Different study types were analyzed. Mutations were identified in 17 studies, totaling 47 mutations. Molecular investigations are essential when standard exams fall short in determining sudden death causes. Expertise in molecular biology is crucial due to diverse genetic conditions. Discrepancies in post-mortem protocols affect the validity of results, making standardization necessary. Multidisciplinary approaches and the analysis of different tissue types are vital.
尽管进行了法医检查,突发意外死亡事件往往仍无法得到解决,这给病理学家带来了挑战。分子尸检通过基因检测,可以揭示标准方法无法检测到的潜在病因。本综述评估了分子尸检在阐明突发意外死亡(SUD)病例中的作用,探讨了其在尸检实践中的方法、效用和有效性。本系统综述遵循PRISMA指南,并在PROSPERO上进行了注册(注册号:CRD42024499832)。在PubMed、Scopus和Web of Science上进行检索,以确定关于猝死病例分子尸检的英文研究(2018 - 2023年)。根据纳入/排除标准记录和筛选所选研究的数据。描述性统计分析了研究范围、组织使用情况、发表国家和期刊。共检索到过去5年的1759篇出版物,排除30篇重复文献。经过详细筛选,又排除1645篇出版物,留下84篇全文文章以供选择。其中,37篇全文文章被选作分析对象。对不同的研究类型进行了分析。在17项研究中鉴定出了突变,共47种突变。当标准检查无法确定猝死原因时,分子调查至关重要。由于存在多种遗传状况,分子生物学专业知识至关重要。死后检验方案的差异会影响结果的有效性,因此有必要进行标准化。多学科方法以及对不同组织类型的分析至关重要。